LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Content-Type:
text/plain; charset="utf-8"
Date:
Sun, 20 Jan 2013 20:02:12 -0500
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Subject:
Re: pituitary tumor
Content-Transfer-Encoding:
quoted-printable
Message-ID:
<[log in to unmask]>
Sender:
Lactation Information and Discussion <[log in to unmask]>
From:
Kathy Lilleskov <[log in to unmask]>
Parts/Attachments:
text/plain (14 lines) 
I am wondering why this mom is being given Bromocriptine when there is a newer and safer (especially for the mother) drug called Dostinex. It does seem possible to reduce supply and continue to breastfeed according to Hale while using Dostinex ... maybe she would be able to reduce her prolactin levels enough to continue breastfeeding and conceive...Anyhow, Bromocriptine is a very nasty drug and Dostinex is much better. Kind of like Reglan v. Domperidone.
Kathy Lilleskov  RN IBCLC (mother of two kiddies conceived on Bromocriptine #1 and Dostinex #2 due to a pituitary microadenoma)

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2